
Loading, please wait...

Loading, please wait...

Dental practitioners frequently rely on plaque disclosing agents to enhance the visualization of oral biofilms during clinical examinations. These dyes play a vital role in educating patients about their oral hygiene effectiveness. While erythrosine has been the gold standard for decades, recent safety concerns and its tendency to cause persistent staining have led to the search for better alternatives.
A recent randomized crossover trial evaluated D&C Red No. 33 against traditional erythrosine. Researchers measured plaque visibility and user acceptability across three different formulations. Although erythrosine provided the highest visibility scores, it also caused significant residual staining on the lips and oral mucosa. Consequently, patients often find this staining aesthetically unappealing after leaving the dental clinic.
Furthermore, the study highlighted that D&C Red No. 33 offers a more favorable balance. It effectively identifies plaque accumulation while remaining easier to remove from soft tissues. Participants in the trial reported higher taste satisfaction with D&C Red No. 33 compared to the bitter profile of erythrosine. Additionally, all tested formulations achieved similar results in reducing plaque indices after routine brushing and flossing procedures.
Specifically, the mixed formulation containing green powder yielded intermediate outcomes. However, it demonstrated the lowest overall plaque visibility among the groups. Therefore, clinicians might prefer pure D&C Red No. 33 for routine disclosures. This transition could potentially improve patient compliance by making the procedure more comfortable and less messy. Moreover, the study supports the safety and efficacy of D&C Red No. 33 as a modern clinical tool.
D&C Red No. 33 offers significantly less residual staining on the lips and oral mucosa compared to erythrosine. Additionally, users report a more pleasant taste and find the stain easier to remove through routine brushing.
While erythrosine provides slightly higher visibility scores, D&C Red No. 33 remains highly effective for clinical plaque detection. It ensures that patients can clearly see biofilm while avoiding the drawbacks of excessive staining.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical or dental advice, diagnosis, or treatment. Always seek the advice of your physician, dentist, or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Sooampon S et al. Evaluation of D&C Red No. 33 as an alternative to erythrosine for plaque disclosure: a randomized crossover trial. BMC Oral Health. 2026 Jun 04. doi: 10.1186/s12903-026-08786-6. PMID: 42243816.
US4302439A. Method of disclosing dental plaque with D and C Red 33. Google Patents. 1981.
Pretty IA et al. Quantification of dental plaque in the research environment. Journal of Dentistry. 2005;33(3):193-207. doi: 10.1016/j.jdent.2004.10.017.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A randomized trial suggests D&C Red No. 33 is a viable alternative to erythrosine for plaque disclosure, offering better taste and less staining....
last month

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today